Clinical Trials
Clinerion partners with Eugen to expand Patient Network Explorer...
Eugen, a clinical development service provider based in Uruguay, will support Clinerion’s expansion by promoting hospitals in the country to join Patient Network Explorer (PNEx),...
Clinical Trials
ImmuPharma signs agreement with Avion for Lupuzor
UK-based pharmaceutical company ImmuPharma has signed a licensing and development agreement with US-based Avion Pharmaceuticals for Lupuzor, a peptide therapeutic and a first-in-class autophagy immunomodulator...
Clinical Trials
Inceptua and Bendalis enter into an exclusive oncology medicine...
The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic...
Clinical Trials
ERYTECH Announces Publication of its Phase 2b Trial of...
ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that the full results from its...
Clinical Trials
Anixa Biosciences collaborates with Urology Centers of Alabama on...
Anixa Biosciences, Inc., a biotechnology company, announced a collaboration with Urology Centers of Alabama (UCA) in the Cchek early prostate cancer detection study. UCA will...
Clinical Trials
Biogen completes enrollment in phase 3 STAR study of...
Biogen Inc, a global biotechnology company, announced the enrollment of the last patient in the global phase 3 STAR clinical study, which is evaluating the...
Clinical Trials
CRISPR Therapeutics, Vertex Report First Data from Trials of...
CRISPR Therapeutics and Vertex Pharmaceuticals reported preliminary, mostly-positive safety and efficacy data from the first two patients enrolled in two Phase I/II trials assessing their...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.